TOP
Nav Bar
  1. General Info
  2. Source Info
  3. Effects Info
  4. Reference
Phytochemical Details
01. General Information
Name Vitamin C
PubChem CID 54670067
Molecular Weight 176.12g/mol
Synonyms

Acid, Ascorbic, Acid, L-Ascorbic, Ascorbate, Ferrous, Ascorbate, Magnesium, Ascorbate, Sodium, Ascorbic Acid, Ascorbic Acid, Monosodium Salt, di-L-Ascorbate, Magnesium, Ferrous Ascorbate, Hybrin, L Ascorbic Acid, L-Ascorbic Acid, Magnesium Ascorbate, Magnesium Ascorbicum, Magnesium di L Ascorbate, Magnesium di-L-Ascorbate, Magnorbin, Sodium Ascorbate, Vitamin C

Formula C₆H₈O₆
SMILES C(C(C1C(=C(C(=O)O1)O)O)O)O
InChI 1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1
InChIKey CIWBSHSKHKDKBQ-JLAZNSOCSA-N
CAS Number 50-81-7
ChEMBL ID CHEMBL40274
ChEBI ID CHEBI:29073
Drug Bank ID DB00126
KEGG ID C00072
Toxicity Organism Test Type Route(Dose)
rat LD50 intraperitoneal(165 mg/kg)
mouse LD50 intraperitoneal(254 mg/kg)
rat LD50 oral(322 mg/kg)
Structure 2D-img
Download
2D MOL 3D MOL
02. Source Information of Phytochemical
(1) Rubus chingii Hu Warm
Chineses Pinyin FuPenZi
Use Part Aggregate Fruit
Habitat AnHui, JiangSu, ZheJiang
Flavor Sweet, Sour
Meridian Tropism Liver, Kidney, Bladder
Species
>Kingdom: Viridiplantae
 -->Phylum: Streptophyta
  -->Class: Equisetopsida
   -->Order: Rosales
    -->Family: Rosaceae
     -->Genus: Rubus
      -->Species: Rubus chingii
(2) Moringa oleifera Warm
Chineses Pinyin LaMu
Species
>Kingdom: Viridiplantae
 -->Phylum: Streptophyta
  -->Class: Equisetopsida
   -->Order: Brassicales
    -->Family: Moringaceae
     -->Genus: Moringa
      -->Species: Moringa oleifera
03. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Drug(s) whose efficacy can be enhanced by this phytochemical
Hide/Show
Combination Pair ID: 533
Pair Name Vitamin C, Erastin
Partner Name Erastin
Disease Info [ICD-11: 2C10] Pancreatic cancer Investigative
Biological Phenomena Induction-->Ferroptosis
Gene Regulation Down-regulation Expression CP hsa1356
Up-regulation Expression HMOX1 hsa3162
Up-regulation Expression NCOA4 hsa8031
Up-regulation Expression NFE2L2 hsa4780
Up-regulation Expression NFE2L2 hsa4780
Up-regulation Phosphorylation PRKAA1 hsa5562
Up-regulation Expression SLC2A1 hsa6513
Down-regulation Expression SLC7A11 hsa23657
In Vitro Model PaTu 8988s Pancreatic adenocarcinoma Homo sapiens (Human) CVCL_1846
BxPC-3 Pancreatic ductal adenocarcinoma Homo sapiens (Human) CVCL_0186
In Vivo Model Panc02 cells (1×10⁵ cells/site) were transfected and subcutaneously injected into 4-week-old C57BL/6 mice to generate xenografts.
Result The combination of erastin and vitamin C exerts a synergistic effect of classical and nonclassical modes to induce ferroptosis in PC cells, which may provide a promising therapeutic strategy for PC.
Combination Pair ID: 534
Pair Name Vitamin C, Anti-PD-1 antibody
Partner Name Anti-PD-1 antibody
Disease Info [ICD-11: 2B33.5] Lymphoma Investigative
Biological Phenomena Inhibition-->Anti-PD1 checkpoint
Gene Regulation Up-regulation Expression GZMB hsa3002
Up-regulation Expression IL12B hsa3593
In Vitro Model A20 Reticulum cell sarcoma Mus musculus (Mouse) CVCL_1940
SU-DHL-6 Diffuse large B-cell lymphoma germinal center B-cell type Homo sapiens (Human) CVCL_2206
OCI-Ly1 Diffuse large B-cell lymphoma Homo sapiens (Human) CVCL_1879
OCI-Ly7 Diffuse large B-cell lymphoma germinal center B-cell type Homo sapiens (Human) CVCL_1881
OCI-Ly3 Diffuse large B-cell lymphoma activated B-cell type Homo sapiens (Human) CVCL_8800
In Vivo Model 40 BALB/c mice received a subcutaneous (s.c.) right flank injection of 5×10⁶ A20 tumor cells in phosphate-buffered saline (PBS) and were randomly assigned to 4 groups of 10 mice: vehicle, anti-PD1 (α-PD1), AA, and AA+α-PD1.
Result This study shows that AA treatment 1) increases immunogenicity of lymphoma cells; 2) enhances intratumoral infiltration of CD8+ T cells and macrophages; and 3) synergizes with anti-PD1 checkpoint inhibition in a syngeneic lymphoma mouse model via marked activation of cytotoxic cells (cytotoxic T cells and NK cells) and antigen presenting cells. The data provide a compelling rationale for testing combinations of high-dose AA and anti-PD1 agents in patients with aggressive B cell lymphoma and in preclinical models of other malignancies.
Combination Pair ID: 535
Pair Name Vitamin C, Cimetidine
Partner Name Cimetidine
Disease Info [ICD-11: 2C60] Breast cancer Investigative
Biological Phenomena Inhibition-->Angiogenesis
Gene Regulation Down-regulation Phosphorylation AKT1 hsa207
Up-regulation Expression CASP3 hsa836
Down-regulation Phosphorylation MTOR hsa2475
Down-regulation Phosphorylation PIK3CA hsa5290
In Vitro Model MCF-7 Invasive breast carcinoma of no special type Homo sapiens (Human) CVCL_0031
In Vivo Model Each mouse in the experimental group received 0.2 mL EAC saline solution (2.5×10⁶ cells) subcutaneously in the mammary fat pad on day 0. Mice were left for 9 days with free access to water and food to develop solid breast cancer.
Result We concluded that the synergistic combination provided a promising anti-neoplastic effect via reducing the angiogenesis, oxidative stress, increasing apoptosis,as well as inhibiting the activation of PI3K/AKT/mTOR cue, and suggesting its use as a treatment option for breast cancer.
Combination Pair ID: 537
Pair Name Vitamin C, Topotecan
Partner Name Topotecan
Disease Info [ICD-11: 2C60] Breast cancer Investigative
Biological Phenomena Induction-->DNA damage
Gene Regulation Up-regulation Expression CDKN1A hsa1026
Up-regulation Expression H2AX hsa3014
Up-regulation Expression TP53 hsa7157
In Vitro Model MCF-7 Invasive breast carcinoma of no special type Homo sapiens (Human) CVCL_0031
Result Synergistic enhancement of topotecan-induced cell death by ascorbic acid in human breast MCF-7 tumor cells.
Combination Pair ID: 538
Pair Name Vitamin C, Methotrexate
Partner Name Methotrexate
Disease Info [ICD-11: 2C60] Breast cancer Investigative
Biological Phenomena Induction-->Blockade of cell cycle in G2/M phase
Gene Regulation Up-regulation Cleavage CASP3 hsa836
Up-regulation Phosphorylation MAPK14 hsa1432
In Vitro Model MDA-MB-231 Breast adenocarcinoma Homo sapiens (Human) CVCL_0062
MCF-7 Invasive breast carcinoma of no special type Homo sapiens (Human) CVCL_0031
Result Combined low-dose vitamin C and MTX had synergistic anti-proliferative/cytotoxic effects on TNBC cells. In addition, co-treatment increased H2O2 levels and activated both caspase-3 and p38 cell death pathways.
Combination Pair ID: 540
Pair Name Vitamin C, Oxaliplatin
Partner Name Oxaliplatin
Disease Info [ICD-11: 2B72] Gastric cancer Investigative
Gene Regulation Up-regulation Activity CASP3 hsa836
Up-regulation Activity CASP7 hsa840
Up-regulation Expression H2AX hsa3014
Down-regulation Expression SLC2A1 hsa6513
In Vitro Model AGS Gastric adenocarcinoma Homo sapiens (Human) CVCL_0139
SGC-7901 Human papillomavirus-related cervical adenocarcinoma Homo sapiens (Human) CVCL_0520
HGC-27 Gastric carcinoma Homo sapiens (Human) CVCL_1279
MGC-803 Gastric mucinous adenocarcinoma Homo sapiens (Human) CVCL_5334
In Vivo Model AGS cells (1×10⁷/mice) were subcutaneously inoculated into the right armpit of the nude mice.
Result The current study showed that GLUT1 expression was inversely correlated with sensitivity of gastric cancer cells to pharmacological ascorbate and suggested that GLUT1 expression in gastric cancer may serve as a marker for sensitivity to pharmacological ascorbate.
Combination Pair ID: 899
Pair Name Vitamin C, Lenvatinib
Partner Name Lenvatinib
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Biological Phenomena Inhibition-->Cell proliferative, migratory and invasive capacities
Gene Regulation Down-regulation Expression MET hsa4233
In Vitro Model Hep 3B2.1-7 Childhood hepatocellular carcinoma Homo sapiens (Human) CVCL_0326
Huh-7 Adult hepatocellular carcinoma Homo sapiens (Human) CVCL_0336
SK-HEP-1 Liver and intrahepatic bile duct epithelial neoplasm Homo sapiens (Human) CVCL_0525
Result Combination of Vitamin C and Lenvatinib potentiates antitumor effects in hepatocellular carcinoma cells in vitro
Combination Pair ID: 901
Pair Name Vitamin C, Oxaliplatin
Partner Name Oxaliplatin
Disease Info [ICD-11: 2B90] Colon cancer Investigative
Biological Phenomena Induction-->Oxidative Stress
Gene Regulation Up-regulation Expression CDH1 hsa999
Down-regulation Expression CDH2 hsa1000
In Vitro Model HCT 116 Colon carcinoma Homo sapiens (Human) CVCL_0291
Result Treatment with the combination of oxaliplatin with vitamin C can inhibit CRC cell growth and decrease cancer cell migration and invasion, via oxidative stress and cadherins.
Drug(s) whose resistance can be reversed by this phytochemical
Hide/Show
Combination Pair ID: 539
Pair Name Vitamin C, Cisplatin
Partner Name Cisplatin
Disease Info [ICD-11: 2B51] Osteosarcoma Investigative
Biological Phenomena Induction-->Glycolysis
Gene Regulation Up-regulation Expression G6PD hsa2539
Up-regulation Expression H2AX hsa3014
Up-regulation Expression HK2 hsa3099
Up-regulation Expression MYC hsa4609
Up-regulation Expression ROS1 hsa6098
Up-regulation Expression SLC16A4 hsa9122
In Vitro Model 143B Osteosarcoma Homo sapiens (Human) CVCL_2270
U2OS Osteosarcoma Homo sapiens (Human) CVCL_0042
Result Our findings provide a rationale for combining cisplatin with ascorbate in therapeutic strategies against OS.
Drug(s) whose toxicity can be decreased by this phytochemical
Hide/Show
Combination Pair ID: 536
Pair Name Vitamin C, GW841819X
Partner Name GW841819X
Disease Info [ICD-11: 2C30] Melanoma Investigative
Gene Regulation Down-regulation Expression BRD4 hsa23476
Down-regulation Expression H4C12 hsa8362
Down-regulation Expression HAT1 hsa8520
Down-regulation Expression HRH4 hsa59340
In Vitro Model A2058 Amelanotic melanoma Homo sapiens (Human) CVCL_1059
SK-MEL-28 Cutaneous melanoma Homo sapiens (Human) CVCL_0526
SK-MEL-2 Melanoma Homo sapiens (Human) CVCL_0069
C8161 Cutaneous melanoma Homo sapiens (Human) CVCL_6813
1205Lu Cutaneous melanoma Homo sapiens (Human) CVCL_5239
In Vivo Model Mice were then engrafted on the neck by injecting 2×10⁵ mouse melanoma cells, B16-F10, to produce experimental tumor.
Result This study shows that ascorbate can enhance the efficacy of BET inhibitors, providing a possible clinical solution to challenges arising in phase I trials from the dose-dependent side effects of this class of epigenetic therapy.
04. Reference
No. Title Href
1 Vitamin C Sensitizes Melanoma to BET Inhibitors. Cancer Res. 2018 Jan 15;78(2):572-583. doi: 10.1158/0008-5472.CAN-17-2040. Click
2 Vitamin C Sensitizes Pancreatic Cancer Cells to Erastin-Induced Ferroptosis by Activating the AMPK/Nrf2/HMOX1 Pathway. Oxid Med Cell Longev. 2022 Jul 19;2022:5361241. doi: 10.1155/2022/5361241. Click
3 High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model. Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1666-1677. doi: 10.1073/pnas.1908158117. Click
4 Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer. Sci Rep. 2022;12(1):11514. Published 2022 Jul 7. doi:10.1038/s41598-022-15551-6 Click
5 Synergistic enhancement of topotecan-induced cell death by ascorbic acid in human breast MCF-7 tumor cells. Free Radic Biol Med. 2017 Dec;113:406-412. doi: 10.1016/j.freeradbiomed.2017.10.377 Click
6 Combined treatment with vitamin C and methotrexate inhibits triple-negative breast cancer cell growth by increasing H2O2 accumulation and activating caspase-3 and p38 pathways. Oncol Rep. 2017 Apr;37(4):2177-2184. doi: 10.3892/or.2017.5439. Click
7 Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation. Theranostics. 2018 Feb 2;8(5):1312-1326. doi: 10.7150/thno.21745. Click
8 Combination of Vitamin C and Lenvatinib potentiates antitumor effects in hepatocellular carcinoma cells in vitro. PeerJ. 2023 Jan 25;11:e14610. doi: 10.7717/peerj.14610. Click
9 Vitamin C Improves the Inhibitory Effects of Oxaliplatin on HCT-116 Colorectal Cancer Growth and Progression Through Cellular Oxidant Function-associated Cadherin Molecules. Anticancer Res. 2023 Oct;43(10):4461-4472. doi: 10.21873/anticanres.16641. Click
10 Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin. Pharmacol Res Perspect. 2020 Aug;8(4):e00632. doi: 10.1002/prp2.632. Click
It has been 46448 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP